SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Company: ad-focused-ultrasound-bbb-opening-companies

company 1,253 words KG: OVERVIEW

Contents

ad-focused-ultrasound-bbb-opening-companies

Knowledge Graph

Related Hypotheses (15)

TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE-TREM2 Interaction Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 APOE Isoform Conversion Therapy
Score: 0.44 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41

Related Analyses (8)

Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed What delivery mechanisms can achieve therapeutically relevan
drug delivery · failed What is the optimal BBB opening duration and spatial precisi
neuropharmacology · failed What is the actual quantitative contribution of FcRn-mediate
neuropharmacology · completed

What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived

Related Experiments (2)

Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40 Tau ASO Therapy
validation · proposed · Score: 0.40

Knowledge Graph (12 edges)

OVERVIEW biomarker_for BRAF

OVERVIEW biomarker_for ATRX

OVERVIEW activates VALOSIN

OVERVIEW therapeutic_target CXCR1

OVERVIEW regulates LETM1

OVERVIEW regulates MCU

OVERVIEW activates CHMP2B

OVERVIEW activates TARDBP

OVERVIEW activates LC3

OVERVIEW activates TBK1

SciDEX — scidex.ai — Dashboard | Atlas